Skip to content

Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis

Improving Diagnosis of COPD Through Characterisation of Comorbidities Present at, and Healthcare Utilisation Prior to, Diagnosis of COPD in UK. A Retrospective Primary Care Database.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01655667
Enrollment
38859
Registered
2012-08-02
Start date
2010-12-31
Completion date
2012-06-30
Last updated
2012-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Diagnosis, Primary Care, Comorbidities, Healthcare utilisation

Brief summary

To characterise and understand the current UK COPD population including demographics, active comorbidities and missed opportunities for COPD diagnosis in the years previous to diagnosis

Detailed description

Using real-world primary care clinical databases, ascertain whether 1) trends in respiratory resource utilisation prior to COPD diagnosis (including lower respiratory tract infections \[LRTIs\], consultations and hospitalisations) could be used as 'flags' to aid earlier diagnosis, and 2) characterize comorbid conditions present at the time of COPD diagnosis, and evaluate the relationship to COPD disease severity and age at diagnosis.

Interventions

None listed

Sponsors

Department of Health, United Kingdom
CollaboratorOTHER_GOV
Research in Real-Life Ltd
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 40 years or older * Electronically coded diagnosis of COPD made between 1990 and 2009 * A minimum of three years continuous practice data including two years prior to and one year post diagnosis to ensure patients recieved COPD therapy post diagnosis * Recieved two or more prescriptions for COPD therapies in the 12 months post diagnosis year 1.

Exclusion criteria

* Aged less than 40 years * No diagnosis of COPD between 1990 and 2009 * Less than three years continuous practice data including two years prior to and one year post diagnosis * Less than two prescriptions for COPD therapies in the 12 months post diagnosis year 1.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026